Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Apolipoprotein E3-Leiden (APOE*3-Leiden) transgenic mice have been used to study the effect of different cholesterol-containing diets on the remnant lipoprotein levels and composition and on the possible concurrent development of atherosclerotic plaques. On high fat/cholesterol (HFC) diet, the high expressing lines 2 and 181 developed severe hypercholesterolemia (up to 40 and 60 mmol/liter, respectively), whereas triglyceride levels remained almost normal when compared with regular mouse diet. The addition of cholate increased the hypercholesterolemic effect of this diet. In lines 2 and 181, serum levels of apo E3-Leiden also increased dramatically upon cholesterol feeding (up to 107 and 300 mg/dl, respectively). In these high expressing APOE*3-Leiden transgenic mice, the increase in both serum cholesterol and apo E3-Leiden occurred mainly in the VLDL/LDL-sized fractions, whereas a considerable increase in large, apo E-rich HDL particles also occurred. In contrast to the high expressing lines, the low expressing line 195 reacted only mildly upon HFC diet. On HFC diets, the high expresser APOE*3-Leiden mice developed atherosclerotic lesions in the aortic arch, the descending aorta, and the carotid arteries, varying from fatty streaks containing foam cells to severe atherosclerotic plaques containing cholesterol crystals, fibrosis, and necrotic calcified tissue. Quantitative evaluation revealed that the atherogenesis is positively correlated with the serum level of cholesterol-rich VLDL/LDL particles. In conclusion, with APOE*3-Leiden transgenic mice, factors can be studied that influence the metabolism of remnant VLDL and the development of atherosclerosis.

[1]  J. Qiao,et al.  Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. , 1993, Science.

[2]  R. Frants,et al.  Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. , 1993, The Journal of biological chemistry.

[3]  M. Katsuki,et al.  Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. , 1992, The Journal of clinical investigation.

[4]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[5]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[6]  A. Tall,et al.  Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. , 1992, The Journal of clinical investigation.

[7]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Katsuki,et al.  Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Lough,et al.  Pathology of atherosclerosis in cholesterol-fed, susceptible mice. , 1991, Atherosclerosis.

[10]  P. de Knijff,et al.  Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. , 1991, The Journal of clinical investigation.

[11]  A. Tall,et al.  Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. , 1991, The Journal of biological chemistry.

[12]  J. Taylor,et al.  Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. , 1991, The Journal of biological chemistry.

[13]  J. Taylor,et al.  In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice. , 1990, The Journal of biological chemistry.

[14]  S M Grundy,et al.  Dietary influences on serum lipids and lipoproteins. , 1990, Journal of lipid research.

[15]  B. Paigen,et al.  Synthetic low and high fat diets for the study of atherosclerosis in the mouse. , 1990, Journal of lipid research.

[16]  R. Mahley,et al.  Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. , 1989, The Journal of clinical investigation.

[17]  B. Paigen,et al.  Atherosclerosis in the mouse , 1989 .

[18]  Cotran Rs,et al.  The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation , 1989 .

[19]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[20]  R. Williams,et al.  Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.

[21]  B. Taylor,et al.  Genetic factors controlling structure and expression of apolipoproteins B and E in mice. , 1987, The Journal of biological chemistry.

[22]  B. Paigen,et al.  Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. , 1987, Atherosclerosis.

[23]  B. Paigen,et al.  Variation in susceptibility to atherosclerosis among inbred strains of mice. , 1985, Atherosclerosis.

[24]  V. Schumaker,et al.  Genetic control of lipid transport in mice. I. Structural properties and polymorphisms of plasma lipoproteins. , 1983, The Journal of biological chemistry.

[25]  Y. Chao,et al.  Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Mahley,et al.  Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. , 1980, The Journal of biological chemistry.

[27]  G. Schonfeld,et al.  Carbohydrate Diet-induced Changes in Very Low Density Lipoprotein Composition and Structure , 1978, Diabetes.

[28]  M. Lopes-Virella,et al.  Cholesterol determination in high-density lipoproteins separated by three different methods. , 1977, Clinical chemistry.